Vienna: In the laboratories of Austria’s universities, where doctoral students plan careers around grant cycles they cannot yet see, the most consequential decision of the year is being taken several hundred kilometres away in committee rooms most of them will never enter. The European Union’s next research programme, successor to Horizon Europe and known for now as FP10, is the largest single pot of competitive science funding on the continent, and its design for the years 2028 to 2034 is being argued over clause by clause this June.
The European Commission has put a budget of roughly 175 billion euros on the table, alongside a restructured architecture that adds a fourth pillar to the programme. National governments were supposed to settle their common position by 29 May, but research ministers left that meeting without a deal, citing insufficient progress on the questions that matter most. The Council is now aiming for what Brussels calls a partial general approach by the end of June, a political agreement among member states on the main parameters that would let negotiations with the European Parliament begin in earnest.
Three arguments are doing most of the blocking. The first is governance and priority setting, the dry-sounding question of who decides what European science is actually for, and how much room politicians should have to steer money toward whatever the strategic anxiety of the moment happens to be. The second is the relationship between FP10 and the proposed Europe Competitiveness Fund, a separate instrument that some governments fear could quietly absorb research money into an industrial-policy machine answerable to different masters. The third is the future of the Widening measures, the support designed to pull less research-intensive member states, mostly in the east and south, closer to the leaders in Germany, the Netherlands and the Nordics.
That last fight is the one with the sharpest distributional edge. Widening countries argue that without ring-fenced help the programme will keep rewarding institutions that are already strong, deepening a two-speed research Europe. Wealthier members counter that excellence should be the only currency, and that money chasing geography rather than quality is money wasted. Both positions have a respectable case, and neither side has shown much appetite for surrender.
What gives the June scramble its urgency is less the calendar than the credibility of European science as an employer. Talented researchers are mobile, and the long uncertainty over FP10 sends a message that the bloc cannot reliably commit to its own people. Every month the framework remains a sketch is a month in which a postdoctoral fellow in Vienna, Lisbon or Tallinn weighs an offer from outside the Union with slightly more interest. The autonomy of the programme, its insulation from short-term political redirection, is not an abstraction to them; it is the difference between a fundable idea and a stranded one.
A compromise this month is still plausible, partly because it does not require another full ministerial meeting and can be brokered at official level. But a partial approach is exactly that, partial, and the hardest trade-offs on the budget envelope will be entangled with the wider negotiation over the Union’s 2028 to 2034 finances, where research must compete with defence, agriculture and migration for a shrinking sense of fiscal room. Scientists watching from their benches have learned to read these signals carefully. For now, the most honest answer to when the money will be settled is the one Brussels least likes to give: not yet.
